Skip to main content
FinSpry Logo
FinSpry
ABBV logo
ABBV
(NYSE)
AbbVie Inc.
$223.07-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AbbVie (ABBV) Stock Price & Financial Analysis

AbbVie Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$226.00 - $230.47
52-Week High$244.81
52-Week Low$181.73
Open$227.37
Volume6.09M
Average Volume (3M)5.89M
Market Cap403.11B
Shares Outstanding1.77B
P/E Ratio (TTM)110.90
Forward P/E125.55
Price to Sales (P/S)6.42
Price to Book (P/B)-124.88
EV/EBITDA22.66
Revenue (TTM)62.82B
Net Income (TTM)3.63B
Free Cash Flow (TTM)17.82B
EPS (TTM)$2.05
Profit Margin5.79%
Operating Margin26.42%
50-Day MA$209.85
200-Day MA$220.02
52-Week Change17.51%
Annual Dividend$6.74
Dividend Yield3.02%
Payout Ratio200.00%
Last Dividend Ex-DateApr 15, 2026

Frequently Asked Questions About AbbVie

What is the current stock price for ABBV?

As of the latest trading session, ABBV stock trades at $227.23. The 52-week range is $181.73–$244.81, with a day range of $226.00–$230.47.

What is the P/E ratio for ABBV?

AbbVie's trailing P/E ratio is 110.9, meaning investors pay $110.9 for every $1 of annual earnings. The forward P/E is 125.5, reflecting analyst expectations for future earnings.

Does ABBV pay dividends?

Yes, AbbVie pays a 3.02% annual dividend yield ($6.74 per share). The payout ratio is 200.0%. The last ex-dividend date was 2026-04-15.

What do analysts recommend for ABBV?

Based on 14 analysts, the consensus for ABBV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABBV?

AbbVie's market capitalization is $403.11B, classifying it as a mega-cap company..